Ridgewood Investments’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Ridgewood Investments's DGX Position: Q3 2025 in Review
Ridgewood Investments sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 200 shares — an estimated $35.9K sold.
Ridgewood Investments first reported a position in DGX in Q2 2020 and held it in 18 quarters. The position peaked at $344K in Q2 2021. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.
- Ridgewood Investments reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
- Ridgewood Investments sold 200 Quest Diagnostics shares in Q3 2025, an estimated $35.9K.
- Ridgewood Investments first reported a position in Quest Diagnostics in Q2 2020 and held it in 18 quarters.
- Ridgewood Investments's Quest Diagnostics position peaked at $344K in Q2 2021.
- 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.
Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.